Tag: PROMISE study
WallabyPhenox announces first patient enrolment in new study evaluating MeVO stroke...
WallabyPhenox has today announced that the first patient has been enrolled in PROMISE—an investigator-initiated, prospective study examining how medium-vessel occlusion (MeVO) acute ischaemic strokes...
“Aspiration first” approach with Penumbra system demonstrates favourable outcomes for acute...
Penumbra announced results of the company-sponsored PROMISE study, demonstrating real-world safety and efficacy of the Penumbra system with ACE 68 and ACE64 reperfusion catheters...
